Genbiopro, INC.
Generic Pharmaceutical Manufacturer
Based in NV
AI Overview
With $500K in lobbying spend across 15 quarterly filings, Genbiopro, INC is an active lobbying client. Their lobbying covers 4 issue areas. Active from 2022 to 2025.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2022 | $80K |
| 2023 | $140K |
| 2024 | $140K |
| 2025 | $140K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Genbiopro, INC. disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Pharmacy, Family Issues, Veterans
Issues related to medication abortion Issues related to abortion access Issues related to FDA Approval of Mifepristone
FDA Approval of generic mifepristone and related Risk Evaluation Mitigation Strategies (REMS).
VA rulemaking on providing abortion services to veterans.
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.